Published in Am J Respir Cell Mol Biol on September 01, 2000
Oxidative stress and antioxidant defense. World Allergy Organ J (2012) 2.35
Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol (2006) 1.86
Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2010) 1.43
Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax (2005) 1.35
Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and periodontal treatment. Clin Oral Investig (2008) 1.12
Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol (2005) 1.10
Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation (2005) 1.04
Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Thorax (2008) 1.03
Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol (2012) 1.00
Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax (2002) 0.98
Gene expression profile of human airway epithelium induced by hyperoxia in vivo. Am J Respir Cell Mol Biol (2006) 0.91
New perspectives on oxidized genome damage and repair inhibition by pro-oxidant metals in neurological diseases. Biomolecules (2014) 0.86
SIRT1 pathway dysregulation in the smoke-exposed airway epithelium and lung tumor tissue. Cancer Res (2012) 0.86
Oxidative stress in asthma. World Allergy Organ J (2011) 0.85
Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg (2005) 0.85
Effects of cigarette smoke on degranulation and NO production by mast cells and epithelial cells. Respir Res (2005) 0.78
New insights into an old story: pollen ROS also play a role in hay fever. Plant Signal Behav (2012) 0.77
Nitric oxide and hyperoxic acute lung injury. Med Gas Res (2016) 0.75
Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease. Sci Rep (2016) 0.75
Lack of association between physical activity in smokers and plasma glutathione peroxidase levels. Cancer Epidemiol Biomarkers Prev (2008) 0.75
Role of oxidative stress & transient receptor potential in chronic obstructive pulmonary disease. Indian J Med Res (2015) 0.75
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis (1979) 3.02
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A (1995) 2.44
NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A (2001) 2.33
Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis (1986) 2.10
Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05
Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun (1985) 1.91
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol (2001) 1.69
Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis (1985) 1.61
Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest (1998) 1.60
Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res (2001) 1.50
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest (1997) 1.48
Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr (1984) 1.47
Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet (2000) 1.43
Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.43
Pulmonary nitric oxide in mountain dwellers. Nature (2001) 1.40
Human vascular endothelial cells express oxytocin receptors. Endocrinology (1999) 1.40
Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages. Pediatr Res (1979) 1.36
Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients. Infect Immun (1981) 1.35
Ultrastructure and function of alveolar macrophages from cystic fibrosis patients. Pediatr Res (1980) 1.22
Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol (1997) 1.21
Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J (2001) 1.19
Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2000) 1.16
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J (2011) 1.14
Biophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP. J Cell Biol (1991) 1.13
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung (2001) 1.10
Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J Immunol (2000) 1.08
Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol (1997) 1.08
Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther (1999) 1.08
Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am J Respir Crit Care Med (1996) 1.07
Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol (1985) 1.07
iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol (1998) 1.05
Alterations in exhaled gas profile during allergen-induced asthmatic response. Am J Respir Crit Care Med (2001) 1.04
Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med (1999) 1.03
Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine (2000) 0.97
Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol (1999) 0.97
Variant forms of DNA polymerase beta in primary lung carcinomas. DNA Cell Biol (1999) 0.97
Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest (1984) 0.96
Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol (1999) 0.93
Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc Natl Acad Sci U S A (2005) 0.91
Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther (1998) 0.90
Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia. Arch Pathol Lab Med (1988) 0.90
Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection. Infect Immun (1982) 0.89
Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Cleve Clin J Med (2001) 0.89
Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. J Clin Microbiol (1986) 0.88
Characterization of inducible nitric oxide synthase expression in human airway epithelium. Environ Health Perspect (1998) 0.88
Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein. J Leukoc Biol (1996) 0.87
Constitutive NF-kappaB levels in human alveolar macrophages from normal volunteers. Cytokine (1998) 0.87
Interleukin-9 receptor expression in asthmatic airways In vivo. Lung (2000) 0.85
Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats. Infect Immun (1984) 0.85
High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol (2001) 0.85
Role of nitric oxide in poly(I-C)-induced endothelial cell expression of leukocyte adhesion molecules. Am J Physiol (1997) 0.84
Role of bronchoscopy in asthma research. Clin Chest Med (1999) 0.84
Phagocytosis of Pseudomonas aeruginosa by polymorphonuclear leukocytes and monocytes: effect of cystic fibrosis serum. Infect Immun (1982) 0.84
Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol (1996) 0.83
Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest (1994) 0.82
Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models. Cancer Immunol Immunother (1993) 0.81
Foreign-body tumorigenesis in mice: DNA synthesis in surface-attached cells during preneoplasia. J Natl Cancer Inst (1978) 0.80
Function of human alveolar macrophages from normal volunteers and cigarette smokers: effect of cystic fibrosis serum. J Leukoc Biol (1984) 0.80
Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1alpha levels in lung transplant patients. Transplantation (2000) 0.80
Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann Allergy Asthma Immunol (1999) 0.79
Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein. J Biol Response Mod (1988) 0.79
Human monocytes produce monocyte chemoattractant protein 1 (MCP-1) in response to a synthetic peptide derived from C-reactive protein. Clin Immunol Immunopathol (1995) 0.78
Double-stranded rna dependence of nitric oxide synthase 2 expression in human bronchial epithelial cell lines BET-1A and BEAS-2B. Am J Respir Cell Mol Biol (2001) 0.77
Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastases. Cancer Immunol Immunother (1994) 0.77
Inhaled corticosteroids and beta-agonists inhibit oxidant production by bronchoalveolar lavage cells from normal volunteers in vivo. Immunopharmacology (1997) 0.77
Flexible bronchoscopy in molecular biology. Clin Chest Med (2001) 0.77
Primary pulmonary hypertension: update on pathogenesis and novel therapies. Cleve Clin J Med (2000) 0.76
Monocyte tumoricidal activity and tumor necrosis factor production in patients with malignant brain tumors. Cancer Immunol Immunother (1991) 0.76
Human lung lysozyme: sources and properties. Am Rev Respir Dis (1981) 0.76
Nitric oxide synthase in the human airway epithelium. Zhongguo Yao Li Xue Bao (1997) 0.76
Foreign-body tumorigenesis: number, distribution, and cell density of preneoplastic clones. J Natl Cancer Inst (1975) 0.75
Immunologic changes in renal cell carcinoma patients receiving gamma interferon. Oncology (1991) 0.75
Gonococcal meningitis: case report and review of the literature. S D J Med (1988) 0.75
Nitric oxide synthase 2 through an autocrine loop via respiratory epithelial cell-derived mediator. Am J Physiol Lung Cell Mol Physiol (2001) 0.75
Transfer ribonucleic acid nucleotidyltransferase activity in virions of type-C viruses. Biochem Biophys Res Commun (1976) 0.75
Bronchoalveolar lavage. Cleve Clin Q (1985) 0.75
Pharmacokinetics of low-dose methotrexate in adult asthmatics. Pharmacotherapy (1992) 0.75
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects. J Immunother Emphasis Tumor Immunol (1993) 0.75
Effect of low-dose methotrexate on the disposition of glucocorticoids and theophylline. J Allergy Clin Immunol (1991) 0.75